On September 18, 2026, Morgan Stanley bought 216,125 shares of CHUNLI MEDICAL (01858) (H shares) on the SEHK open market at an average of HKD 7.4942 per share, involving about HKD 1.62 million, marking its first notifiable interest in the company. This is an on-exchange active trade, a direct dealing in the secondary market.
Prior to the acquisition, Morgan Stanley's long position in CHUNLI MEDICAL was 4.54 million shares, representing 4.77%; following the acquisition, the holding changed to 4.76 million shares, with the long position ratio rising to 5.0%.